MPNEsupport Org 802492-1069, Sweden

Melanoma Patient Network Europe

Tell us about your Melanoma

clinical trial experience

If you are a Melanoma patient or carer and you live in the European Union, we want to hear from you!

GetReal is a project that aims to develop ideas for new, alternative trial designs that better incorporate patient perspectives and real-world data (how a treatment works in real life, rather than in traditional clinical trials) into drug development. To do this, we need understand the experience of patients and carers with traditional clinical trials and ask for ideas about what could make trials better in the future.

Find out more and take part in our anonymous

Thank you for your efforts- the survey is now closed.



Last update 17th April 2015, BR

MPNE 2015

Annual conference

24th- 26th April 2015​

Boulevard Adolphe Max 98

1000 Brussels - Belgium

MPNE 2015

Friday- 24th April


13.30- 15.15
Workshop I

Dermoscopy- Part I What does a good skin exam look like?
Dermoscopy workshop for Melanoma Patient Advocates.
Zrinjka Patar. Ana-Maria Forsea, Monika Gniadecka, Selma Ataly

​Room: TATI 2

Workshop II
Therapy options in Stage IV Melanoma.

Pascal Wolter, UZ Leuven, Belgium

Therapies in Stage 4 Melanoma have been evolving very rapidly in the last few years. Join this workshop to understand what the latest therapies are about and what their advantages and disadvantages are. Submit your questions HERE to make sure they get answered!

Room: Forman

Workshop III
Psychosocial support in Melanoma.

Stefania Bassino

Room: Polanski

GetReal- Focus session

for GetReal working group

Room: Tati 1

15.15- 15.45

15.45- 17.30
Workshop IV 

Dermoscopy- Part II with practical exercises.

Develop a MPNE recommendation: The good skin exam.
Room: Tati 2

Workshop V
Therapy options for Stage III Melanoma.

Dirk Schadendorf, University hospital Essen, Germany

Submit your questions in Stage 3 Melanoma HERE.

Room: Polanski

EMA Focus group with Stage IV patients and carers
How do Melanoma patients assess risks and benefits of novel therapies?
Room: Forman